Fidelity Management leads $36 mln round for Scholar Rock
Scholar Rock said Monday it raised $36 million in a Series B financing round led by Fidelity Management and Research Company. New investor Cormorant Asset Management also participated as well as existing investors Polaris Partners, Timothy Springer, ARCH Venture Partners, EcoR1 Capital and The Kraft Group. Cambridge, Massachusetts-based Scholar Rock, a biotechnology company, discovers and develops drugs that selectively target supracellular activation of growth factors in the disease microenvironment.
4 January 2016•3 mins read
